We will like to share with you the following articles by HSA:
(Click the title of the article to read more)
In this issue, their editorial team brings you updates on the recall of three brands of losartan products found to contain trace amounts of a nitrosamine impurity (NMBA), safety information associated with the use of fluoroquinolones, hydrochlorothiazide and SGLT2-inhibitors; an educational ‘AE Case in Focus’ article on lipoid pneumonia suspected with the excessive use of essential oils and our annual analysis of adverse event reports for 2018.
The editorial team is also pleased to present you with the ‘List of new drugs registered in 2018’ poster along with this issue.
The news bulletin is posted on the MOH Health Professional Portal and HSA’s website.
